Drug Data for Clinical Decision Support

Are you developing EMRs and practice management systems where speed to market is critical?

Monday, December 19, 2011 by David Wilkof

Clinical Decision Support
Are you developing EMRs and practice management systems where speed to market is critical?   One of the modules of such systems is the inclusion of drug information.    Since this is neither the expertise of your developers nor your content people,  it is important to identify the preferred drug information provider early in the process.   Four criteria are critical in making this decision.   First, quality of information.  Second,  flexibility of design and APIs.   Third, simplicity of data structure.   Fourth, and very important, customer support during the development period and after release.    More and more EMRs are now using Lexicomp drug information as part of their offering.  And there is a reason for that.


Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database.  This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification,  Drug Classifications, dose range checking (adult and pediatric), Patient Education, Pediatric and neonatal drug interactions and more. 


Comments for Are you developing EMRs and practice management systems where speed to market is critical?

Leave a comment





Captcha